Merck
All Photos(2)

1.02144

SAFC

Calcium hydrogen phosphate

anhydrous, fine powder, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 341(ii)

Synonym(s):
Calcium hydrogen phosphate, Calcium orthophosphate, Calcium phosphate dibasic
Empirical Formula (Hill Notation):
HCaO4P
CAS Number:
Molecular Weight:
136.06
MDL number:
E Number:
E341 (ii)
EC Index Number:
231-826-1

Agency

BP
Ph. Eur.
USP

Quality Level

reg. compliance

FCC

product line

EMPROVE® ESSENTIAL

form

fine powder

potency

10000 mg/kg LD50, oral (Rat)
>7940 mg/kg LD50, skin (Rabbit)

particle size

(see specification)

pH

7 (20 °C, 10 g/L in H2O, suspension)

mp

370 °C (decomposition)

density

2.89 g/cm3 at 20 °C

application(s)

pharmaceutical
semi-solid formulation
solid formulation

storage temp.

2-30°C

InChI

1S/Ca.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+2;/p-2

InChI key

FUFJGUQYACFECW-UHFFFAOYSA-L

Compare Similar Items

View Full Comparison

1 of 4

This Item
307653V90002513204
Calcium hydrogen phosphate anhydrous, fine powder, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 341(ii)

SAFC

1.02144

Calcium hydrogen phosphate

agency

BP, Ph. Eur., USP

agency

-

agency

-

agency

-

product line

EMPROVE® ESSENTIAL

product line

-

product line

Vetec

product line

-

form

fine powder

form

powder

form

powder

form

powder

pH

7 (20 °C, 10 g/L in H2O, suspension)

pH

-

pH

-

pH

-

mp

370 °C (decomposition)

mp

-

mp

-

mp

-

density

2.89 g/cm3 at 20 °C

density

2.31 g/mL at 25 °C (lit.)

density

2.31 g/mL at 25 °C (lit.)

density

-

General description

To address challenges of solid formulation manufacturing, we have developed a comprehensive product portfolio to meet with your solid dosage needs in mind. Although solid dose formulations are one of the the most established dosage forms in the pharmaceutical market, the complexity of manufacturing final drug products is becoming more and more challenging. API stability, release kinetics and bioavailability limitations, such as low API solubility, are just a few of many critical obstacles on the way to the market.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Calcium hydrogen phosphate is a commonly used ingredient in both food and pharmaceutics. In pharmaceutical applications, calcium hydrogen phosphate is primarily used as a filler/binder.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

What is the Emprove® Program?

The Emprove® Program is a system providing comprehensive and thorough documentation of our filters and single-use components, pharma raw materials, and starting materials.

Material Qualification Dossier

Free of charge - Sign in to download

Quality Management Dossier (Open Access)

Free of charge - Sign in to download

Operational Excellence Dossier

Available by subscription or for a fee

Learn more about the benefits an Emprove® Program subscription can provide
Why are these documents unavailable?
Emprove® Dossiers contain information intended to support the registration process and risk assessment activities of pharmaceutical producers and contain confidential information. Please contact us if you would like access.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service